Bien qu’ils ne soient pas stricto sensu membres du laboratoire, nous avons inclus dans cette liste certaines publications des Pr D Riethmuller et JJ Baldauf, membres actifs de l’EA3181,  référents
nationaux pour les pathologies du col de l’utérus et la vaccination contre les HPV et certaines publications du Pr Aubin qui fait aussi partie de l’EA3181,  un des référents nationaux pour les pathologies cutanées associées aux HPV.

Leur activité au sein de notre réseau est essentielle pour la bonne harmonisation des pratiques cliniques et de laboratoire et pour la reconnaissance de notre activité de recherche.

  • PUBLICATIONS INTERNATIONALES

    • Plissonnier ML, Fauconnet S, Bittard H, Mougin C, Rommelaere J, Lascombe I. Cell death and restoration of TRAIL-sensivity by ciglitazone in resistant cervical cancer cells. Oncotarget 2017
     
    • Guenat D, Hermetet F, Prétet JL, Mougin C. Exosomes and other extracellular vesicles in HPV transmission and carcinogenesis. Viruses 2017; 9(8). pii: E211
     
    • Haelens A, Roche L, Bastos J, Woronoff AS, Zorzi M, Francart J, Grell Eurocare-5 working group. Trends in net survival from cervical cancer in six European Latin countries: results from the SUDCAN population-based study. Eur J Cancer Prev 2017; 26: S92-S99
     
    • Lacau St Guilly J, Rousseau A, Baujat B, Périé S, Schultz P, Barry B, Dufour X, Malard O, Pretet JL, Clavel C, Birembaut P, Franceschi S. Oropharyngeal cancer prognosis by tumour HPV status in France: The multicentric Papillophar study. Oral Onco 2017; 67:29-36
     
    • Lefevre M, Rousseau A, Rayon T, Dalstein V, Clavel C, Beby-Defaux A, Prétet JL, Soussan P, Polette M, Lacau Saint Guily J, Birembaut P; Papillophar Study Group. Epithelial to mesenchymal transition and HPV infection in squamous cell oropharyngeal carcinomas: the papillophar study. Br J Cancer 2017; 116: 362-369
     
    • Moitry M, Jéqu J, Averous G, Velten M, Fender M, Akladios C, Baldauf JJ. Reporting reactive cellular changes on smears among women who undergo cervical cancer screening: results of a cohort study after seven years of follow-up. Eur J Obstet Gynecol Reprod Biol 2017; 216:232-238
     
    • Morel A, Baguet A, Perrard J, Demeret C, Jacquin E, Guenat D, Mougin C, Prétet JL. 5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression. Oncotarget 2017; 8(28):46163-46176
     
    • Oswald E, Reinz E, Voit R, Aubin F, Alonso A, Auvinen E. Human papillomavirus type 8 E7 protein binds nuclear myosin 1c and downregulates the expression of pre-rRNA. Virus Genes 2017
     
    • Thiery A, Akladios C, Fender M, Severac F, Baldauf JJ. Excess cervical cancer screening smears: any benefit? A retrospective cohort in Alsace, France. J Med Screen 2017; 24(2):92-97
     
    • Vuitton L, Jaillet C, Jacquin E, Monnien F, Heberle M, Mihai MI, Lassabe C, Raffoul J, Puyraveau M, Lakkis Z, Lamfichekh N, Picard A, Prétet JL, Mougin C, Valmary-Degano S. Human papillomaviruses in colorectal cancers: A case-control study in western patients. Dig Liver Dis 2017; 49: 446-450
     
    • Guenat D, Launay S, Riethmuller D, Mougin C, Prétet JL. Validation of Novaprep® HQ+ liquid-based cytology medium for high-risk human papillomavirus detection by hc2. Infect Agents Cancer 2016; 11: 41
     
    • Hermetet F, Jacquin E, Launay S, Gaiffe E, Couturier M, Hirchaud F, Sandoz P, Prétet JL, Mougin C. Efferocytosis of apoptotic human papillomavirus-positive cervical cancer cells by human primary fibroblasts. Biol Cell 2016; 108: 189-204
     
    • Neumann F, Jégu J, Mougin C, Prétet JL, Guizard AV, Lapôtre-Ledoux B, Bara S, Bouvier V, Colonna M, Troussard X, Trétarre B, Grosclaude P, Velten M, Woronoff AS. Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: A population-based study. Prev Med. 2016; 90: 52-58
    • Akladios C, Lecointre L, Baulon E, Thoma V, Averous G, Fender M, Lefebvre F, Baldauf JJ. Reliability of endocervical curettage in the diagnosis of high-grade cervical neoplasia and cervical cancer in selected patients. Anticancer Res. 2015 Jul; 35(7): 4183-9 
     
    • Barth H, Morel A, Mougin C, Averous G, Legrain M, Fender M, Risch S, Fafi-Kremer S, Velten M, Oudet P, Baldauf JJ, Stoll-Keller F. Long-term storage and safe retrieval of human papillomavirus DNA using FTA elute cards. J Virol Methods 2016; 229: 60-65
     
    • Bellaud G, Gheit T, Pugin A, Prétet JL, Tommasino M, Mougin C, Aubin F. Prevalence of human polyomavirus DNA in eyebrow hairs plucked from patients with psoriasis treated with TNF inhibitors. J Eur Acad Dermatol Venereol 2015; 29: 1019-1021
     
    • Riethmuller D, Jacquard AC, Lacau St Guily J, Aubin F, Carcopino X, Pradat P, Dahlab A, Prétet JL. Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France. BMC Public Health 2015; 15: 453
     
    • Jégu J, Belot A, Borel C, Daubisse-Marliac L, Trétarre B, Ganry O, Guizard AV, Bara S, Troussard X, Bouvier V, Woronoff AS, Colonna M, Velten M. Effect of previous history of cancer on survival of patients with a second cancer of the head and neck. Oral Oncol 2015; 51: 457-463
     
    • Viguier M, Bachelez H, Poirier B, Kagan J, Battistella M, Aubin F, Touzé A, Carmagnat M, Francès C, Gougeon ML, Fazilleau N. Peripheral and local human papillomavirus 16-specific CD8+ T-cell expansions characterize erosive oral lichen planus. J Invest Dermatol 2015; 135: 418-424
     
    • Luquain A, Belglaiaa E, Guenat D, Vrecko S, Riethmuller D, Valmary-Degano S, Bedgedjian I, Chouham S, Prétet JL, Mougin C. High prevalence of abnormal cervical smears in underscreened French women beyond the upper age limit screening program. Prev Med 2015; 81: 157-162
     
    • Belglaiaa E, El annaz H, Mouaouya B, Aksim M, Mercier M, Prétet JL, Chouham S, Mougin C. Human papillomavirus genotypes among women with or without HIV infection: An epidemiological study of Moroccan women from the Souss area. Infect Agents Cancer 2015; 10: 44
     
    • Martin M, Mougin C, Prétet JL, Gil H, Meaux-Ruault N, Puzenat E, Ramanah R, Aubin F, Touzé A, Coursaget P, Jacquin E, Magy-Bertrand N. Screening of human papillomavirus infection in women with systemic sclerosis. Clin Exp Rheumatol 2014; 32(6 Suppl 86): S-145-148
     
    • Roche E, Lascombe I, Bittard H, Mougin C, Fauconnet S. The PPARβ agonist L-165041 promotes VEGF mRNA stabilization in HPV18-harboring HeLa cells through a receptor-independent mechanism. Cell Signal 2014; 26: 433-443.
     
    • Akladios C, Ronzino V, Schrot-Sanyan S, Afors K, Fernandes R, Baldauf JJ, Wattiez A. Comparison between trans-peritoneal and extra-peritoneal laparoscopic para-aortic lymphadenectomy in gynecologic malignancies. J Minim Invasive Gynecol 2014; S1553-4650(14)01474-5
     
    • Prétet JL, Guenat D, Riethmuller D, Mougin C. New HPV16 viral biomarkers to understand the progression of cervical lesions towards cancer. Indian J Med Res 2014; 139: 487-489
     
    • Baudu A, Prétet JL, Riethmuller D, Chotard M, Mougin C, Mercier M. Prevalence and risk factors of human papillomavirus infection types 16/18/45 in a cohort of French females aged 15-23 years. J Epidemiol Glob Health 2014; 4: 35-43
     
    • Jégu J, Colonna M, Daubisse-Marliac L, Trétarre B, Ganry O, Guizard AV, Bara S, Troussard X, Bouvier V, Woronoff AS, Velten M. The effect of patient characteristics on second primary cancer risk in France. BMC Cancer 2014; 14: 94
     
    • Hirchaud F, Hermetet F, Ablise M, Fauconnet S, Vuitton DA, Prétet JL, Mougin C. Isoliquiritigenin induces caspase-dependent apoptosis via downregulation of HPV16 E6 expression in cervical cancer Ca Ski cells. Planta Med 2013; 79: 1628-1635
     
    • Le Borgne G, Mercier M, Woronoff AS, Guizard AV, Abeilard E, Caravati-Jouvenceaux A, Klein D, Velten M, Joly F. Quality of life in long-term cervical cancer survivors: a population-based study. Gynecol Oncol 2013; 129: 222-228
     
    • Valmary-Degano S, Jacquin E, Prétet JL, Monnien F, Girardo B, Arbez-Gindre F, Joly M, Bosset JF, Kantelip B, Mougin C. Signature patterns of human papillomavirus type 16 in invasive anal carcinoma. Hum Pathol 2013; 44: 992-1002.
    • Li J, Bonifati S, Hristov G, Marttila T, Valmary-Degano S, Stanzel S, Schnölzer M, Mougin C, Aprahamian M, Grekova SP, Raykov Z, Rommelaere J, Marchini A. Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas. EMBO Mol Med 2013; 5: 1537-1555
     
    • Jacquin E, Saunier M, Mauny F, Schwarz E, Mougin C, Prétet JL. Real-time duplex PCR for simultaneous HPV 16 and HPV 18 DNA quantitation. J Virol Methods 2013; 193: 498-502
     
    • Jacquin E, Baraquin A, Ramanah R, Carcopino X, Morel A, Valmary-Degano S, Bravo IG, de Sanjosé S, Riethmuller D, Mougin C, Prétet JL. Type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR. J Clin Microbiol 2013; 51: 3207-3215
     
    • Kim S, Jary M, Mansi L, Benzidane B, Cazorla A, Demarchi M, Nguyen T, Kaliski A, Delabrousse E, Bonnetain F, Letondal P, Bosset JF, Valmary-Degano S, Borg C. DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising treatment for recurrent advanced squamous cell anal carcinoma. Ann Oncol 2013; 24: 3045-3050
     
    • Viennet C, Gheit T, Muret P, Aubin F, Cabou J, Marchal A, Tommasino M, Humbert P. Assessment of the efficacy of a new formulation for plantar wart mummification: new experimental design and human papillomavirus identification. Clin Exp Dermatol 2013; 38: 85-88
     
    • Penso-Assathiany D, Gheit T, Prétet JL, Aubin A, Tommasino M, Mougin C, Braun R, Chosidow O, Aubin F. Presence and persistence of human papillomavirus types 1, 2, 3, 4, 27, and 57 on dermoscope before and after examination of plantar warts and after cleaning. J Am Acad Dermatol 2013; 68: 185-186
     
    • Aubin F, Gheit T, Prétet JL, Tommasino M, Mougin C. Effect of Infliximab on the UVB-Induced Apoptosis of Keratinocytes Infected by HPV38 E6/E7. ISRN Dermatol 2013; 2013: 907189.
    • Gaiffe E, Prétet JL, Launay S, Jacquin E, Saunier M, Hetzel G, Oudet P, Mougin C. Apoptotic HPV positive cancer cells exhibit transforming properties. PLoS One 2012; 7(5):e36766
     
    • Prétet JL, Mercier M, Riethmuller D, Aubin F, Vuitton D, Mougin C. Human papillomavirus and cardiovascular disease. J Am Coll Cardiol 2012; 60: 81-82
     
    • Abramowitz L, Jacquard AC, Jaroud F, Haesebaert J, Siproudhis L, Pradat P, Aynaud O, Leocmach Y, Soubeyrand B, Dachez R, Riethmuller D, Mougin C, Prétet JL, Denis F. Human papillomavirus genotype distribution in anal cancer in France: The EDiTH V study. Int J Cancer 2011; 129:433-9
     
    • Lacau St Guily J, Clavel C, Okais C, Prétet JL, Beby-Defaux A, Agius G, Birembaut P, Jacquard AC, Leocmach Y, Soubeyrand B, Riethmuller D, Denis F, Mougin C. Human papillomavirus genotype distribution in tonsil cancers. Head Neck Oncol 2011; 07: 1-6
     
    • Aubin F, Martin M, Puzenat E, Magy-Bertrand N, Segondy M, Riethmuller D, Wendling D. Genital human Papillomavirus infection in patients with autoimmune inflammatory diseases. Joint Bone Spine 2011; 78: 460-465
     
    • Guerrini JS, Bouvard V, Oswald E, Alonso A, Prétet JL, Tommasino M, Mougin C, Aubin F. E6 and E7 proteins from different beta-papillomaviruses types do not interfere in UVB-induced apoptosis of HaCaT keratinocytes. Exp Dermatol 2011; 20: 71-73
     
    • St Guily JL, Jacquard AC, Prétet JL, Haesebaert J, Beby-Defaux A, Clavel C, Agius G, Birembaut P, Okaïs C, Léocmach Y, Soubeyrand B, Pradat P, Riethmuller D, Mougin C, Denis F. Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France-The EDiTH VI study. J Clin Virol 2011; 51: 100-104
     
    • St Guily JL, Clavel C, Okaïs C, Prétet JL, Beby-Defaux A, Agius G, Birembaut P, Jacquard AC, Léocmach Y, Soubeyrand B, Riethmuller D, Denis F, Mougin C. Human papillomavirus genotype distribution in tonsil cancers. Head Neck Oncol 2011; 3: 6
     
    • Abramowitz L, Jacquard AC, Jaroud F, Haesebaert J, Siproudhis L, Pradat P, Aynaud O, Leocmach Y, Soubeyrand B, Dachez R, Riethmuller D, Mougin C, Prétet JL, Denis F. Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study. Int J Cancer 2011; 129: 433-439
     
    • Brun JL, Dalstein V, Leveque J, Mathevet P, Raulic P, Baldauf JJ, Scholl S, Huynh B, Douvier S, Riethmuller D, Clavel C, Birembaut P, Calenda V, Baudin M, Bory JP. Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy. Am J Obstet Gynecol 2011; 204: 169
     
    • Aubin F, Gheit T, Prétet JL, Tommasino M, Mougin C, Chosidow O. Presence and persistence of human papillomavirus types 1, 2 and 4 on emery boards after scraping off plantar warts. J Am Acad Dermatol 2010; 62: 151-153
     
    • Galeano-Zea JA, Sandoz P, Gaiffe E, Prétet JL, Mougin C. Pseudo-periodic encryption of extended 2D surfaces for high accurate recovery of any random zone by vision. Int J Optomechatronics 2010; 4: 65-82
     
    • Biver-Dalle C, Gheit T, Drobacheff-Thiebaut C, Vidal C, Tommasino M, Humbert P, Prétet JL, Mougin C, Aubin F. Human papillomavirus in plucked eyebrow hairs of HIV patients: an analysis of 25 genus-bêta, genus-alpha et 6 genus gamma-types. J Invest Dermatol 2010; 130: 2499-2502
     
    • Prétet JL, Vidal C, Le Bail Carval K, Ramanah R, Carcopino X, Cartier I, Labouyrie E, Kantelip B, Coumes-Marquet S, Riethmuller D, Mougin C. Novaprep® Vial Test is a suitable liquid based-cytology medium for high risk human papillomavirus testing by Hybrid Capture 2. J Clin Virol 2010; 49: 286-289
     
    • Decrion-Barthod AZ, Bosset M, Plissonnier ML, Marchini A, Nicolier M, Launay S, Prétet JL, Rommelaere J, Mougin C. Histone deacetylase inhibitor sodium butyrate with protein kinase inhibitor UCN-01 has marked in in vitro and in vivo antitumour activity against cervical cancer cells. Anticancer Res 2010; 30: 4049-4061
     
    • Dalstein V, Merlin S, Bali C, Saunier M, Dachez R, Ronsin C. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus. J Virol Methods 2009; 156: 77-83
     
    • Nicolier M, Decrion-Barthod AZ, Launay S, Prétet JL, Mougin C. Spatiotemporal activation of caspase-dependent and –independent pathways in staurosporine-induced apoptosis of p53wt and p53mt human cervical carcinoma cells. Biol Cell 2009; 101: 455-467
     
    • Saiag P, Bauhofer A, Bouscarat F, Aquilina C, Ortonne JP, Dupin N, Mougin C. Imiquimod 5 % cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open label, noncomparative study. Br J Dermatol 2009; 161: 904-909
     
    • Klug S, Ressing M, Koenig J, Abba MC, Agorastos T, Brenna SM, Ciotto M, Das BR, Del Mistro A, Dybikowska A, Giuliano AR, Gudleviciene Z, Gyllensten U, Haws AL, Helland A, Herrington CS, Hildesheim A, Humbey O*, Jee SH, Kim JW, Madeleine MM, Menczer J, Ngan HY, Nishikawa A, Niwa Y, Pegoraro R, Pillai MR, Ranzani G, Rezza G, Rosenthal AN, Roychoudhury S, Saranath D, Schmitt VM, Sengupta S, Settheetham-Ishida W, Shirasawa H, Snijders PJ, Stoler MH, Suarez-Rincon AE, Szarka K, Tachezy R, Ueda M, Van Der Zee AG, Von Knebel Doeberitz M, Wu MT, Yamashita T, Zehbe I, Blettner M. TP53 codon 72 polymorphism and cervical cancer: pooled analysis of individual data from 49 studies. Lancet Oncol 2009; 10: 772-784 (*PhD EA3181)
     
    • Ruer JB, Pépin L, Gheit T, Vidal C, Kantelip B, Tommasino M, Prétet JL, Mougin C, Aubin F. Detection of alpha- and beta-human papillomavirus (HPV) in cutaneous melanoma: a matched and controlled study using specific multiplex PCR combined with DNA microarray primer extension. Exp Dermatol 2009; 18: 857-862
     
    • Mo LZ, Monnier-Benoit S, Kantelip B, Petitjean A, Riethmuller D, Prétet JL, Mougin C. Comparison of AMPLICOR and Hybrid Capture II assays for high risk-HPV detection in normal and abnormal liquid-based cytology: use of INNO-LiPA Genotyping assay to screen the discordant results. J Clin Virol 2008 41: 104-110
     
    • Prétet JL, Jacquard AC, Carcopino X, Monnier-Benoit S, Averous G, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D, for the EDITH study group. Human Papillomavirus (HPV) genotype distribution in high grade cervical lesions (CIN 2/3) in France. (EDITH* study). Int J Cancer 2008, 122: 424-427
     
    • Prétet JL, Jacquard AC, Carcopino X, Charlot JF, Bouhour D, Kantelip B, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D, for the EDITH study group. Human Papillomavirus (HPV) genotype distribution in invasive cervical cancers in France. (EDITH* study). Int J Cancer 2008, 122: 428-432
     
    • Colonna M, Danzon A, Delafosse P, Mitton N, Bara S, Bouvier AM, Ganry O, Guizard AV, Launoy G, Molinie F, Sauleau EA, Schvartz C, Velten M, Grosclaude P, Tretarre B. Cancer prevalence in France: Time trend, situation in 2002; and extrapolation to 2012. Eur J Cancer 2008; 44: 115-122
     
    • Prétet JL, Jacquard AC, Saunier M, Clavel C, Dachez R, Gondry J, Pradat P, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D, for the EDiTH study group. Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer: the EDiTH III study. Gynecol Oncol 2008 110: 179-184
     
    • Aubin F, Prétet JL, Jacquard AC, Saunier M, Carcopino X, Jaroud F, Pradat P, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D, for EDiTH study group. Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV). Clin Infect Dis 2008 ; 47: 610-615
     
    • Saunier M, Monnier-Benoit S, Mauny F, Dalstein V, Briolat J, Riethmuller D, Kantelip B, Schwarz E, Mougin C, Prétet JL. Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16 -infected women with high-grade lesions or cervical carcinoma. J Clin Microbiol 2008; 46: 3678-3685
     
    • Lu XM, Monnier-Benoit S, Mo LZ, Xu SY, Prétet JL, Liu Z, Vuitton DA, Mougin C. Human papillomavirus in esophageal squamous cell carcinoma of the high-risk Kazakh ethnic group in Xinjiang, China. Eur J Surg Oncol 2008; 34: 765-770
     
    • Sandoz P, Zeggari R, Froehly L, Prétet JL, Mougin C. Position referencing in optical microscopy thanks to sample holders with out-of-focus encoded patterns. J Microscopy 2007; 225: 293-303
     
    • Mermet I, Guerrini JS, Cairey-Remonnay S, Drobacheff C, Faivre B, Gaillard M, Kantelip B, Prétet JL, Riethmuller D, Humbert P, Aubin F. Cervical intraepithelial neoplasia associated with epidermo-dysplasia verruciformis HPV in a HIV-infected patient: a manifestation of immune restauration syndrome. Eur J Dermatol 2007; 17 : 149-152
     
    • Clere N, Bermont L, Fauconnet S, Lascombe I, Saunier M, Vettoretti L, Plissonnier ML, Mougin C. The human papillomavirus type 18 E6 oncoprotein induces vascular Endothelial Growth Factor 121 transcription from the promoter through a p53-independent mechanism. Exp Cell Research 2007; 313: 3239-3250
     
    • Briolat J, Dalstein V, Saunier M, Joseph K, Caudroy S, Prétet JL, Birembaut P, Clavel C. HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN. Int J Cancer 2007; 121: 2198-2204
     
    • Monnier-Benoit S, Dalstein V, Lalaoui N, Riethmuller D, Mougin C, Prétet JL. Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions. J Clin Virol 2006; 35: 270-277
     
    • Charlot JF, Nicolier M, Prétet JL, Mougin C. Modulation of p53 transcriptional activity by PRIMA-1 and Pifithrin-alpha on staurosporine-induced apoptosis of wild-type and mutated p53 epithelial cells. Apoptosis 2006; 11: 813-827
     
    • Monnier-Benoit S, Mauny F, Riethmuller D, Guerrini JS, Capilna M, Felix S, Seilles E, Mougin C, Prétet JL. Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix. Gynecol Oncol 2006; 102: 22-31
     
    • Guerrini JS, Prétet JL, Mougin C, Aubin F. Human papillomavirus in melanoma. Br J Dermatol 2006; 164: 572
     
    • Dalstein V, Riethmuller D, Sautiere Jl, Prétet JL, Kantelip B, Schaal JP, Mougin C. Detection of cervical precancer and cancer in a hospital population : benefits of HPV testing. Eur J Cancer 2004; 40 : 1225-1232
     
    • Charlot JF, Prétet JL, Haughey C, Mougin C. Mitochondrial translocation of p53 and mitochondrial membrane potential (ΔΨm) dissipation are early events in staurosporine-induced apoptosis of wild type and mutated p53 epithelial cells. Apoptosis 2004; 9: 333-343
     
    • Bard E, Riethmuller D, Meillet D, Prétet JL, Schaal JP, Mougin C, Seilles E. High-risk papillomavirus infection is associated with altered antibody responses in genital tract: Non-specific responses in HPV infection. Viral Immunol 2004; 17: 381-389
     
    • Prétet JL, Dalstein V, Monnier-Benoit S, Delpeut S, Mougin C. High risk HPV load estimated by Hybrid Capture II® correlates with HPV16 load measured by real time PCR in cervical smears of HPV16-infected women. J Clin Virol 2004; 31: 140-147
     
    • Humbey O, Cairey-Remonnay S, Guerrini JS, Algros MP, Mougin C, Bittard H, Aubin F. Detection of the human papillomavirus and analysis of the TP53 polymorphism of exon 4 at codon 72 in penile squamous cell carcinomas. Eur J Cancer 2003, 39: 684-690
     
    • Bernard B, Prétet JL, Charlot JF, Mougin C. Human papillomaviruses type 16+ and 18+ cervical carcinoma cells are sensitive to staurosporine-mediated apoptosis. Biol Cell 2003, 95: 17-26
     
    • Dalstein V, Riethmuller D, Prétet JL, Sautiere Jl, Carbillet JP, Kantelip B, Schaal JP, Mougin C. Persistence and load of high risk HPV are predictors for development of high grade cervical lesions. A longitudinal French cohort study. Int J Cancer 2003, 106: 396-403
     
    • Drobacheff C, Dupont P, Mougin C, Bourezane Y, Challier, Fantoli M, Bettinger D, Laurent R. Anal human papillomavirus DNA screening by Hybrid Capture II in human immunodeficiency virus-positive patients with or without anal intercourse. Eur J Dermatol 2003, 13: 367-371
     
    • Bard E, Riethmuller D, Biichle S, Meillet D, Prétet JL, Mougin C, Seilles E. Validation of a high sensitive immunoenzymatic assay to establish the origin of immunoglobulins in female genital secretions. J Immunoassay Immunochem 2002; 23: 145-162
     
    • Humbey O, Aubin F, Cairey Remonay S, Riethmuller D, Prétet JL, Fest T, Seilles E, Mougin C.TP53 polymorphism at exon 4 in Caucasian women from Eastern France : lack of correlation with HPV status and grade of cervical precancerous lesions. Eur J Obstet Gynecol Reprod Biol 2002; 103 : 60-64
     
    • Cairey Remonnay S, Humbey O, Mougin C, Algros MP, Mauny F, Kanitakis J, Euvrard S, Laurent R, Aubin F. TP53 polymorphism of exon 4 at codon 72 in cutaneous squamous cell carcinoma and benign epithelial lesions of renal transplant recipients and immunocompetent individuals: lack of correlation with HPV status. J Invest Dermatol 2002; 118: 1026-1031
     
    • Aubin F, Puzenat E, Arveux P, Louvat P, Quencez E, Humbert Ph. Genital squamous cell carcinoma in men treated by photochemotherapy. A cancer registry-based study from 1978 to 1998. Br J Dermatol 2001; 144: 1204-1206
     
    • Bernard B, Fest T, Prétet JL, Mougin C. Staurosporine-induced apoptosis of HPV positive and negative human cervical cancer cells from different points in the cell cycle. Cell Death Diff 2001; 8: 234-244
     
    • Bettinger D, Bernard B, Riethmuller D, Greslin I, Gay C, Lab M, Seilles E, Mougin C. Human papillomavirus detection by non isotopic in situ hybridization, in situ hybridization signal amplification and in situ polymerase chain reaction. Eur J Histochem 1999; 43: 185-198
     
    • Riethmuller D, Gay C, Bertrand X, Arveux P, Bettinger D, Carbillet JP, Lassabe C, Seilles E, Schaal JP, Mougin C. Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy as determined by Hybrid CaptureTM II and a PCR-based method. Diagn Mol Pathol 1999; 8: 157-164
     
    • Touze A, Le Mehdaoui S, Sizaret PY, Mougin C, Munoz N, Coursaget P. The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system. J Clin Microbiol 1998, 36: 2046-2051
     
    • Mougin C, Didier JM, Bettinger D, Madoz L, Coumes-Marquet S, Lab M. In situ PCR to cells and to wax sections. An alternative to in situ hybridization for the detection of low copies of human papillomavirus and cytomegalovirus DNA. Methods Mol Biol 1997; 71 : 77-97
     
    • Butor C, Duquenne O, Mignon-Godefroy K, Mougin C, Guillet JG. Solid phase cytometry allows rapid in situ quantitation of human papillomavirus infected cells in biopsy material. Cytometry 1997; 29 : 292-297
     
    • Didier JM, Mougin C, Bettinger D, Vallet A, Bernard C, Kantelip JP, Lab M. Evaluation of a solution chemiluminescent hybridization assay for identification of human papillomavirus from paraffin-embedded tissues. J Eur Acad Dermatol Venereol 1996; 7: 240-246
     
    • Le Cann P, Touze A, Enogat N, Leboulleux D, Mougin C, Legrand MC, Calvet C, Afoutou J, Coursaget P. Detection of antibodies against the Human Papillomavirus type 16 virions by means of an ELISA using recombinant HPV 16 L1 capsids produced by recombinant baculovirus. J Clin Microbiol 1995, 33: 1380-1382
     
    • Le Cann P, Chabaud M, Leboulleux D, Mougin C, Legrand MC, Calvet C, Mayelo V, Afoutou J, Coursaget P. Detection of antibodies to L1, L2 and E4 proteins of human papillomavirus types 6b, 11 and 16 by ELISA using synthetic peptides. J Med Virol 1995 ; 45: 410-414
     
    • Mougin C, Bernard C, Schaal JP, Carbillet JP, Lab M. Detection of human cytomegalovirus in female and male anogenital lesions undergoing HPV-dysplatic changes. Cancer Detect Prevent 1995; 19: 316-324
     
    • Bernard C, Mougin C, Laurent R, Lab M. Oncogene activation: an informative marker for the HPV-lesions severity. Cancer Detect Prevent 1994; 18: 273-282
     
    • Bernard C, Mougin C, Lab M. Recent advances in understanding the pathogenesis of HPV-induced anogenital lesions. Eur Acad Dermatol Venereol 1994; 3: 237-250
     
    • Bernard C, Rossel M, Mougin C, Joannes M, Carbillet JP, Schaal JP, Laurent R, Lab M. Evaluation of Biohit HPV Screening and Typing kits in detection of human papillomavirus DNA from lesions of anogenital tract. Diagn Mol Pathol 1994; 3: 192-199
     
    • Bernard C, Mougin C, Bettinger D, Didier JM, Lab M. Detection of human papillomavirus by in situ polymerase chain reaction in paraffin-embedded cervical biopsies. Mol Cell Probes 1994; 8: 337-344
     
    • Grossin N, Picard C, Mougin C, Tousignon J, Crickx B, Belaich CS. In situ hybridization results in malignant changes of seborrheic keratosis. Eur J Dermatol 1992; 2: 21-24
     
    • Mougin C, Bernard C, Drobacheff C, Rossel M, Bastian P, Lab M, Laurent R. Prevalence of oncogenic human papillomavirus DNA in lesions of the anogenital region of immunodeficiency virus seropositive men : correlation between histological features and in situ hybridization signal. Eur J Dermatol 1992; 2: 231-236
     
    • Bernard C, Mougin C, Madoz L, Drobacheff C, Van Landuyt H, Laurent R, Lab M. Viral coinfections in Human Papillomavirus associated anogenital lesions according to the serostatus for the Human Immunodeficiency Virus. Int J Cancer 1992; 52: 731-737
     
    • Mougin C, Schaal JP, Bassignot A, Madoz L, Coaquette A, Laurent R, Lab M. Detection of human papillomavirus and human cytomegalovirus in cervical lesions by in situ hybridization using biotinylated probes. Biomed Pharmacother 1991; 45: 353-357

  • PUBLICATIONS NATIONALES

    • Bouscarat F, Pelletier F, Fouéré S, Janier M, Bertolloti A, Aubin F. [External genital warts (condylomata)]. Ann Dermatol Venereol 2016; 143(11): 741-745.
     
    • Bouvret P, Mougin C, Prétet JL, Meurisse A, Bonnetain F, Fiteni F. [Practices and attitudes regarding HPV vaccination among general practitioners from Besançon]. J Gynecol Obstet Biol Reprod 2016; 45: 972-978
    • Guenat D, Riethmuller D, Ramanah R, Morel A, Aubin F, Mougin C, Prétet JL. [Molecular diagnosis of human papillomaviruses (HPV): What test(s) in clinical practice? J Gynecol Obstet Biol Reprod 2016; 45: 1009-1019
     
    • Nahet A, Boublenza L, Hassaine H, Masdoua N, Prétet JL, Belglaiaa E, Mougin C. HPV DNA genotyping: a study of anogenital, head and neck and skin cancers in a population from west Algerian. Bull Cancer 2016; 103: 455-460
     
    • Lecointre L, Akladios CY, Averous G, Lefebvre F, Baulon E, Thoma V, Fender M, Baldauf JJ. [Reliability of endocervical curettage after conservative treatment of intraepithelial neoplasia of the cervix.]. J Gynecol Obstet Biol Reprod 2015; 44: 145-153
     
    • Baldauf JJ, Baulon E, Thoma V, Akladios CY. [Prevention of obstetrical complications following LEEP, is it possible?]. J Gynecol Obstet Biol Reprod 2014; 43: 19-25
     
    • Baldauf JJ, Akladios CY, Fender M. [Vulnerable populations: how shall we improve cervical cancer screening?]. Rev Prat 2014; 64: 792-793
     
    • Binder-Foucard F, Bossard N, Delafosse P, Belot A, Woronoff AS, Remontet L. [French network of cancer registries (Francim). Cancer incidence and mortality in France over the 1980-2012 period: solid tumors]. Rev Epidemiol Sante Publique 2014; 62: 95-108
     
    • Lépinoy A, Lescut N, Lassabe C, Bosset JF, Servagi-Vernat S. [Glassy cell carcinoma: a rare cervical neoplasm. Case report of two patients and review of the literature]. Cancer Radiother 2014; 18: 211-214
     
    • Riethmuller D, Ramanah R, Carcopino X, Levêque J. [The follow up of the women vaccinated against HPV.]. J Gynecol Obstet Biol Reprod 2013; 42: 525-533
     
    • Baldauf JJ, Baulon E, Thoma V, Woronoff AS, Akladios CY. [Obstetric outcomes following LOOP-excision]. J Gynecol Obstet Biol Reprod 2013; 42: 534-540
     
    • Aubin F. [Vaccination against human papillomavirus]. Ann Dermatol Venereol 2012; 139: 339-343
     
    • Riethmuller D. [HPV vaccines: the current disorder and the absolute necessity of returning to basics]. J Gynecol Obstet Biol Reprod 2011; 40: 385-386
     
    • Lavoué V, Bergeron C, Riethmuller D, Daraï E, Mergui JL, Baldauf JJ, Gondry J, Douvier S, Lopès P, De Reilhac P, Quéreux C, Letombe B, Marchetta J, Boulanger JC, Levêque J. [Cervical screening: toward a new paradigm ?]. J Gynecol Obstet Biol Reprod 2010; 39: 102-115
     
    • Prétet JL, Riethmuller D, Mougin C. Actualités sur le génotypage HPV. RéfleXions en Gynécologie-Obstétrique 2010; 11: 5-8
     
    • Mougin C, Prétet JL. Cancérogenèse du col de l’utérus et papillomavirus. Ref Gynecol Obstet 2010; 13 :283-298
     
    • Riethmuller D. L’infection à papillomavirus humain : aspects gynécologiques. Médecine Thérapeutique Pédiatrie 2010; 13: 43-49
     
    • Jacquard AC, Denis F, Prétet JL, Aubin F, Pradat P, Riethmuller D. Epidémiologie des génotypes de papillomavirus (HPV) dans les lésions anogénitales en France. Médecine Thérapeutique Pédiatrie 2010; 13: 80-83
     
    • Riethmuller D, Brun JL. Le point sur le vaccin HPV. Médecine Thérapeutique Pédiatrie 2010; 13: 84-91
     
    • Riethmuller D. [Vaccination against papillomavirus]. Rev Prat 2010; 60: 1359-1362
     
    • Lavoué V, Bergeron C, Riethmuller D, Daraï E, Mergui JL, Baldauf JJ, Gondry J, Douvier S, Lopès P, de Reilhac P, Quéreux C, Letombe B, Marchetta J, Boulanger JC, Levêque J. [Cervical screening: toward a new paradigm?]. J Gynecol Obstet Biol Reprod 2010; 39: 102-115
     
    • Riethmuller D, Levêque J. [Cervical cancer prevention in France: more Pap to screen more?]. J Gynecol Obstet Biol Reprod 2009; 38: 199-202
     
    • Riethmuller D, Prétet JL, Denis F, Aubin F, Pradat P, Clavel C, Dachez R, Gondry J, Carcopino X, Mougin C. [Expected impact of a quadrivalent HPV vaccine in France]. J Gynecol Obstet Biol Reprod 2009; 38: 389-395
     
    • Mougin C, Bourgault-Villada I, Coursaget P. [HPV immunization for the prevention of cervical cancer]. Presse Med 2009; 38: 1750-1768
     
    • Riethmuller D, Prétet JL, Denis F, Aubin F, Pradat P, Clavel C, Dachez R, Gondry J, Carcopino X, Mougin C. [Expected impact of a quadrivalent HPV vaccine in France]. J Gynecol Obstet Biol Reprod 2009; 38: 389-395
     
    • Riethmuller D. [Cervical cancer screening: restoration or reconstruction?]. Gynecol Obstet Fertil 2009; 37: 671-679
     
    • Alain S, Aubert M, Aumaitre H, Beytout J, Bloch K, Bouhour D, Callamand P, Caulin E, Chave C, Cheymol J, Denis F, Derrough T, Dodet B, Duclos A, Dunais B, Gagneur A, Gaillat J, Gillet Y, Gras-le-Guen C, Hanslik T, Hau-Rainsard I, Lorrot M, Malvy D, Marchou B, Minodier P, Mory O, Paccalin M, Parez N, Perpoint T, Picherot G, Pinquier D, Prétet JL, Regnier F, Roblot P, Rogeaux O, Sana C, Savagner C, Stephan JL, Strady C, Soubeyrand B, Weil-Olivier C. [Update in vaccinations ?]. Med Mal Infect 2009; 39: 212-224
     
    • Jacquard AC, Denis F, Prétet JL, Aubin F, Pradat P, Riethmuller D. Distribution des génotypes de Papillomavirus humain (HPV) dans les lésions génitales en France : études EDiTH. Bulletin épidémiologique hebdomadaire (BEH) 2009; 29: 313-317
     
    • Mougin C, Nicolier M, Decrion-Barthod AZ. [HPV and cancers: oncogenesis mechanisms]. Revue Francophone des Laboratoires 2008; 405: 35-42
     
    • Riethmuller D, Ramanah R, Prétet JL, Mougin C. [Integrating HPV testing for primary screening?]. J Gynecol Obstet Biol Reprod 2008; 37 Suppl 1: S1 39-51
     
    • Riethmuller D, Gabelle C, Ramanah R, Sautière JL, Prétet JL, Schaal JP, Kantelip B, Mougin C, Maillet R. [Importance of human papillomavirus (HPV) screening in the follow-up after CIN2-3 treatment]. J Gynecol Obstet Biol Reprod 2008; 37: 329-337
     
    • Aubin F, Prétet JL, Mougin C, Riethmuller D. [Human papillomavirus infection]. Ann Dermatol Venereol 2007; 134 : 94-99
     
    • Aubin F, Guerrini JS. [Clinical and benign aspects of human papillomavirus-associated lesions]. Bull Acad Natl Med 2007; 191: 585-599
     
    • Riethmuller D, Guerrini JS, Aubin F. [Intraepithelial lesions and neoplasia associated with human papillomavirus infection]. Bull Acad Natl Med 2007; 191: 601-609
     
    • Prétet JL, Charlot JF, Mougin C. [Virological and carcinogenic aspects of HPV]. Bull Acad Natl Med 2007; 191: 611-623
     
    • Nicolier M, Guerrini JS. Compte Rendu de Congrès: 4th International Meeting of the Cutaneous HPV Consortium and 3rd Meeting of the Cancéropôle Grand Est-DKFZ Heidelberg Joint Programme. Besançon (France), 27-30 Juin 2007; Bull Cancer 2007; 94: 1026-1028
     
    • Riethmuller D. Conduite à tenir devant un test HPV positif. Réalités en Gynécologie Obstétrique 2007; 118: 1-5
     
    • Brun JL, Riethmuller D. [Prophylactic and therapeutic vaccination against human papillomavirus]. J Gynecol Obstet Biol Reprod 2007; 36: 631-641
     
    • Aubin F. Infections à papillomavirus: faut-il vacciner les hommes ? Concours Médical 2007; 129 : 16
     
    • Riethmuller D. [Ano-genital papillomavirus infections in women]. Rev Prat 2006; 56: 1893-1900
     
    • Aubin F, Drobacheff C. [Ano-genital papillomavirus infections in men]. Rev Prat 2006; 56: 1901-1903
     
    • Aubin F, Laurent R. [Human papillomavirus-associated cutaneous lesions]. Rev Prat 2006; 56: 1905-1913
     
    • Prétet JL, Alvarez E, Monnier-Benoit S, Touze A. [Vaccination against human papillomavirus infections]. Rev Prat 2006; 56: 1914-1918
     
    • Riethmuller D, Mougin C.  Place du test HPV. Perspectives : dépistage primaire combiné. Revue du Praticien Gynécologie Obstétrique 2006; 99: 31-32
     
    • Aubin F. [Human papillomavirus infection. Screening treatment and vaccination]. Rev Prat 2006; 56: 1875-1876
     
    • Mougin C, Mo L, Dalstein V. [Natural history of papillomavirus infections]. Rev Prat 2006; 56: 1883-1889
     
    • Mougin C, Nicolier M, Mo L. [Mechanisms of papillomavirus-associated carcinogenesis]. Rev Prat 2006; 56: 1890-1892
     
    • Mougin C, Dalstein V, Prétet JL. L’infection génitale à papillomavirus humains : histoire naturelle, épidémiologie et rôle dans la carcinogenèse du col utérin. Réalités en Gynécologie-Obstétrique 2005 :106
     
    • Pelletier F, Drobacheff-Thiebaut C, Aubin F, Venier Ag, Mougin C, Laurent R. [Effects of imiquimod on latent human papillomavirus anal infection in HIV-infected patients]. Ann Dermatol Venereol 2004; 131 : 947-951
     
    • Gay C, Jacquin H, Madoz L, Mougin C. Papillomavirus humains et grossesse. Gynéco Prat 2004; 168 : 21
     
    • Mougin C, Dalstein V. Epidémiologie, histoire naturelle et détection des infections à papillomavirus humains (HPV). BioTribune 2004; 9 : 16-18
     
    • Riethmuller D. Intérêt de l’introduction à la nomenclature du test de détection des HPV. BioTribune 2004; 9 : 20-23
     
    • Riethmuller D, Mougin C, Schaal JP. Place du typage viral dans le dépistage du cancer du col. Spectra Bio 2004; 23: 43-48
     
    • Gay C, Terzibachian Jj, Gabelle C, Reviron S, Ramanah R, Mougin C. [Carbon dioxide laser vaporization of genital condyloma in pregnancy]. Gynecol Obstet Fertil 2003; 31: 214-219
     
    • Aubin F, Humbey O, Guérrini Js, Mougin C, Laurent R. [Non-melanoma skin cancers and human papillomavirus]. Ann Dermatol Venereol 2003; 130: 1131-1138
     
    • Riethmuller D, Lebail Carval K, Dalstein V, Mougin C, Schaal JP. Place actuelle du typage viral dans le dépistage du cancer du col. Rev Prat 2002; 64 : 1-5
     
    • Riethmuller D, Schaal JP, Mougin C. [Epidemiology and natural history of genital infection by human papillomavirus]. Gynecol Obstet Fertil 2002; 30 : 139-146
     
    • Prétet JL, Mougin C. Les papillomavirus humains : des condylomes au cancer. Actualités Innovations Médecine octobre 2002; 83
     
    • Derancourt C, Mougin C, Chopard Lallier M, Coumes-Marquet S, Drobacheff C, Laurent R. [Oncogenic human papillomaviruses in extra-genital Bowen disease revealed by in situ hybridization]. Ann Dermatol Venereol 2001; 128: 715-718
     
    • Mougin C, Prétet JL, Dalstein V. Papillomavirus humains et cancer du col de l’utérus. Place d’un test de biologie moléculaire dans le dépistage. Spectra Bio 2001; 20: 29-37
     
    • Riethmuller D. Suivi des lésions intraépithéliales de haut grade. Gynéco Prat 2001; 133 : 16
     
    • Aubin F, Humbey O, Humbert P, Laurent R, Mougin C. [Melanoma: role of ultraviolet radiation: from physiology to pathology]. Presse Med 2001; 30 : 546-551
     
    • Mougin C, Dalstein V, Prétet JL, Gay C, Schaal JP, Riethmuller D. [Epidemiology of cervical papillomavirus infections. Recent knowledge]. Presse Med 2001; 30: 1017-1023
     
    • Riethmuller D. [Physiopathology and epidemiology of HPV anogenital diseases]. Ann Dermatol Vénéréol 2000; 127: 3S5-3S9
     
    • Riethmuller D, Seilles E. [Immunity of the female genital tract mucosa and mechanisms of papillomavirus evasion]. J Gynécol Obstet Biol Reprod 2000; 29 : 729-740
     
    • Laurent R, Drobacheff C, Dupont P, Bettinger D, Bourezane Y, Challier B, Mougin C. Infections anales latentes à HPV-DNA chez des patients VIH positifs : intérêt du dépistage et d’un suivi prospectif. Ann Dermatol Venereol 2000; 127 : S23-S24
     
    • Mougin C, Humbey O, Gay C, Riethmuller D. [Human papillomaviruses, cell cycle and cervical cancer]. J Gynecol Obstet Biol Reprod 1999; 29: 13-20
     
    • Berthier S, Mougin C, Vercherin P, Desmurs H, Gil H, De Waziere B, Dupond JL. [Does a particular risk associated with papillomavirus infections exist in women with lupus?] Rev Méd Int 1999; 20: 128-132
     
    • Voltz JM, Drobacheff C, Derancourt C, Coumes Marquet S, Mougin C, Laurent R. [Papillomavirus-induced anogenital lesions in 121 HIV seropositive men. Clinical, histological, viral study, and evolution]. Ann Dermatol Vénéréol 1999; 126: 424-429
     
    • Seilles E, Riethmuller D, Mougin C. [Biology of the papillomavirus infections: V. Vaccine developments]. Ann Biol Clin 1999; 57: 517-524
     
    • Seilles E, Greslin I, Mougin C. [Biology of papillomavirus infections. IV. Sero-epidemiological data]. Ann Biol Clin 1999; 57: 393-400
     
    • Greslin I, Mougin C, Seilles E. [The biology of papillomavirus infections. III. Immune response]. Ann Biol Clin 1998; 56: 267-276
     
    • Mougin C, Bernard B, Lab M. [Biology of papillomavirus infections. II. Their role in the carcinogenesis of the cervix]. Ann Biol Clin 1998; 56: 21-28
     
    • Mougin C, Bernard B, Lab M. [Biology of papillomavirus infections. I. General characteristics]. Ann Biol Clin 1997; 55: 553-563
     
    • Madoz L, Mougin C, Bettinger D. La PCR in situ. Biofutur 1996, 156: A1-A12
     
    • Laurent R, Mougin C. Les infections anogénitales à papillomavirus chez les patients infectés par le VIH. Nouv Dermatol 1995; 14: 92-95
     
    • Didier JM, Mougin C, Paterlini P, Kantelip JP, Brechot C, Lab M. [Cyclin A mRNA expression in human papillomavirus-induced squamous intraepithelial lesions of the anogenital tract]. CR Seances Soc Biol Fil 1995; 189: 111-126
     
    • Van Landuyt H, Mougin C, Drobacheff C, Bernard C, Merle C, Lab M, Laurent R. [Anogenital papillomavirus lesions in humans with or without HIV infection. Comparison of colposcopic, histopathological and virological results]. Ann Dermatol Vénéréol 1993; 120: 281-286
     
    • Bernard C, Mougin C, Rossel M, Laurent R, Lab M. [Study by in situ hybridization of the prevalence of herpes virus as cofactors of the tumoral development of papillomatous lesions of the anogenital region in seropositive and seronegative men against HIV]. CR Seances Soc Biol Fil 1992; 186: 231-241

  • DIRECTION D'OUVRAGES ET CHAPITRES D'OUVRAGES

    Ouvrages
     Aubin F, Prétet JL, Mougin C. Papillomavirus humains. Biologie et pathologie tumorale. Eds. : EM Inter,Tec et Doc, Paris, 2003, 759 p, 89 planches.
     
    Chapitres d’ouvrages
    • Le Cann P, Leboulleux D, Bernard C, Calvet C, Legrand MC, Lesage G, Postec E, Mougin C, Afoutou J, Coursaget P. Detection of antibodies to L1, L2 and E4 gene products of human papillomavirus types 6, 11 and 16 among HPV infected patients and controls. In Stanley M : Immunology of human papillomavirus. Ed. : Plenum Press, New York, 1994, Pp 109-111
     
    • Gay C, Terzibachian JJ, Arveux P, Andreoletti JB, Mougin C, Bettinger D, Madoz L, Knoepffler F. Management of cervical squamous intraepithelial lesions (in diagnosis, treatment and follow-up). Colposcopy or HPV DNA testing ? In : Testa R, Jakob CA, Huguet JO. Cervical Pathology and Colposcopy. Monduzzi Editore SpA, Bologna, 1999, Pp 287-290
     
    • Riethmuller D, Gay C, Bertrand X, Arveux P, Bettinger D, Carbillet JP, LASSABE C, Seilles E, Schaal JP, Mougin C. Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy as determined by Hybrid CaptureTM II and a PCR-based method. In: Testa R, Jakob CA, Huguet JO. Cervical Pathology and Colposcopy. Monduzzi Editore SpA, Bologna, 1999, Pp 333-337
     
    • Prétet JL, Mougin C, Aubin F. Rayonnement UV et papillomavirus humains. In : Aubin F, Humbert P. Rayonnement ultraviolet et peau. Ed. : John Libbey Eurotext, 2001 : Pp 110-115
     
    • Mougin C, Bernard C. Histoire de la découverte des lésions à papillomavirus. In : Aubin F, Prétet JL, Mougin C. Papillomavirus humains. Biologie et pathologie tumorale. Eds. : EM Inter,Tec et Doc, Paris, 2003, Pp 3-11
     
    • Mougin C, Prétet JL. Structure et classification des papillomavirus. In : Aubin F, Prétet JL, Mougin C. Papillomavirus humains. Biologie et pathologie tumorale. Eds. : EM Inter,Tec et Doc, Paris, 2003, Pp 15-24
     
    • Aubin F, Humbey O, Guerrini JS, Prétet JL, Mougin C. HPV et ultraviolets. In : Aubin F, Prétet JL, Mougin C. Papillomavirus humains. Biologie et pathologie tumorale. Eds : EM Inter,Tec et Doc, Paris, 2003, Pp 125-138
     
    • Seilles E. HPV et immunité muqueuse. In : Aubin F, Prétet JL, Mougin C. Papillomavirus humains. Biologie et pathologie tumorale. Eds. : EM Inter,Tec et Doc, Paris, 2003, Pp155-170
     
    • Prétet JL, Bourgault-Villada I. Immunité cellulaire au cours des infections à HPV. In : Aubin F, Prétet JL, Mougin C. Papillomavirus humains. Biologie et pathologie tumorale. Eds. : EM Inter,Tec et Doc, Paris, 2003, Pp 171-186
     
    • Dalstein V, Prétet JL, Mougin C. Histoire naturelle de l’infection cervicale à HPV muqueux. In : Aubin F, Prétet JL, Mougin C. Papillomavirus humains. Biologie et pathologie tumorale. Eds. EM Inter,Tec et Doc, Paris, 2003, Pp 287-307
     
    • Laurent R, Drobacheff C, Aubin F. Epidémiologie des infections à HPV chez les patients infectés par le virus de l’immunodéficience humaine. In : Aubin F, Prétet JL, Mougin C. Papillomavirus humains. Biologie et pathologie tumorale. Eds. : EM Inter,Tec et Doc, Paris, 2003, Pp 371-385
     
    • Riethmuller D, Schaal JP. Lésions bénignes et précancéreuses du col de l’utérus. In : Aubin F, Prétet JL, Mougin C Papillomavirus humains. Biologie et pathologie tumorale Eds. : EM Inter,Tec et Doc, Paris, 2003, Pp 473-482
     
    • Puzenat E, Humbert P, Laurent R, Aubin F. HPV et cancers cutanés. In : Aubin F, Prétet JL, Mougin C. Papillomavirus humains. Biologie et pathologie tumorale. Eds. : EM Inter,Tec et Doc, Paris, 2003, Pp 483-493
     
    • Cairey-Remonnay S, Laurent R, Aubin F. HPV et épidermodysplasie verruciforme. In : Aubin F, Prétet JL, Mougin C. Papillomavirus humains. Biologie et pathologie tumorale. Eds : EM Inter,Tec et Doc, Paris, 2003, Pp 495-500
     
    • Riethmuller D, Sautiere JL, Schaal JP. Traitement des néoplasies intraépithéliales du col utérin. In : Aubin F, Prétet JL, Mougin C Papillomavirus humains. Biologie et pathologie tumorale Eds. : EM Inter,Tec et Doc, Paris, 2003, Pp 627-633
     
    • Lorchel F, Fantoli M, Truc G, Maingon P, Bosset JF. HPV et lésions bénignes, précancéreuses et cancéreuses du canal anal. In : Aubin F, Prétet JL, Mougin C. Papillomavirus humains. Biologie et pathologie tumorale. Eds. : EM Inter,Tec et Doc, Paris, 2003, Pp 549-559
     
    • Aubin F. Traitement des lésions cutanées à HPV par rétinoïdes. In : Aubin F, Prétet JL, Mougin C. Papillomavirus humains. Biologie et pathologie tumorale. Eds. : EM Inter,Tec et Doc, Paris, 2003, Pp 681-685
     
    • Mougin C, Dalstein V. Papillomavirus humains et carcinogenèse. In: F Trivin. Thesaurus de biologie Clinique. Ed : FM/BIO 2005, Pp 207-22
     
    • Riethmuller D, Schaal JP, Mougin C. Faut-il modifier le dépistage primaire ? Place du test HPV. Ed. : CNGOF. VIGOT Paris 2005
     
    • Prétet JL, Saunier M, Mo LZ, Mougin C. Infections à HPV à bas risque et à haut risque, convergences et différences fondamentales. Biologie, l’essentiel pour le clinicien. In : Monsonego J. Traité des infections et pathologies génitales à papillomavirus. Ed. :Springer Verlag, Paris 2007, Pp 3-11
     
    • Riethmuller D. Dépistage du cancer du col en France. Connaissances actuelles : Apport du test HPV. In : Monsonego J. Traité des infections et pathologies génitales à papillomavirus. Ed. Springer Verlag, Paris 2007, Pp 151-159
    • Bouscarat F, Pelletier F, Drobacheff-Thiebaut C, Aubin F. Condylomes ano-génitaux. In : Janier M. Les maladies sexuellement transmissibles. Ed. : Elsevier-Masson 2009, Pp 106-115
     
    • Riethmuller D, Tholozan AS, Ramanah R. Dépistage et prévention des cancers gynécologiques. In Carcopino X, Levêque J, Riethmuller D. Cancers gynécologiques pelviens. Eds : Elsevier Masson 2013, Pp 101-121
     
    • Prétet JL, Valmary-Degano S, Jacquin E, Riethmuller D, Mougin C. Biologie des cancers génitaux de la femme. In Carcopino X, Levêque J, Riethmuller. Cancers gynécologiques pelviens. Eds. : Elsevier Masson 2013, Pp 141-154
     
    • Prétet JL, Guenat D, Riethmuller D, Mougin C. Critères de qualité d’un « bon » test HPV ? In Hédon B, Deruelle P, Graesslin O. Mises à jour en Gynécologie Médicale. Diffusion Vigot – Paris, 2014, Pp 529-542
     
    • Riethmuller D, Mendel A, Ramanah R, Prétet JL, Mougin C. HPV et lésions glandulaires. In Hédon B, Deruelle P, Graesslin O. Mises à jour en Gynécologie Médicale. Diffusion Vigot – Paris. Eds : 2014, Pp 529-542